David Southwell: CEO of Volastra Therapeutics

Feb. 28, 2026 Season: 8 Duration: 31:26 Episode: 88
Portrait of David Southwell

David Southwell, CEO of Volastra Therapeutics, shares his insights about leadership in biopharma and how Volastra is working to discover and develop oncology therapeutics targeting chromosomal instability, a vulnerability of cancers.

Gemini Therapeutics employee in lab.
Gemini Therapeutics

We See Disease Differently
Alexion Patient portrait
Alexion Pharmaceuticals

Patient Videos
Psivant Employees in front of monitor with molecular model.
Psivant Therapeutics

Designing Better Therapeutics, Atom by Atom